Last reviewed · How we verify
NCT06769516
Exercise and Vagus Nerve Stimulation in IBS
NA trial testing Auricular Vagus Nerve Stimulation (aVNS) in Irritable Bowel Syndrome (IBS) in 90 participants. Completed in 1 January 2025.
1 November 2024
Quick facts
| Lead sponsor | Bahçeşehir University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 1 June 2024 |
| Primary completion | 1 November 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Auricular Vagus Nerve Stimulation (aVNS)
- Aerobic Exercise Therapy
- Low FODMAP Diet Intervention
Conditions studied
- Irritable Bowel Syndrome (IBS) — all drugs for Irritable Bowel Syndrome (IBS) →
Sponsor
Bahçeşehir University
Who can join
Adults 18 to 65, any sex, with Irritable Bowel Syndrome (IBS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study was to consider the possible role of exercise and vagus nerve on bowel functionality in chronic IBS and to demonstrate that exercise and transcutaneous auricular stimulation of the vagus nerve can reduce these symptoms in the treatment of these patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06769516
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Irritable Bowel Syndrome (IBS)
Currently open trials in the same condition.
- NCT07481422 — Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndro · Phase 1, PHASE2 · recruiting
- NCT07261826 — Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics · recruiting
- NCT07000227 — Mechanism of FODMAP Restriction on FGID Patients · NA · recruiting
- NCT06647043 — Evaluate the Effect of Synbiotics in Irritable Bowel Syndrome · NA · recruiting
- NCT06668922 — Irritable Bowel Syndrome and Control Volunteers: Diet Challenge · NA · recruiting
Other Bahçeşehir University trials
Trials by the same sponsor.
- NCT07475819 — Posture Exercises and Ergonomics Education · NA · not yet recruiting
- NCT07453654 — Eye Exercises and Self-Cervical Mobilization in Office Workers With Neck Pain · NA · not yet recruiting
- NCT07471204 — Evaluation of Muscle Oxygenation and Recovery Dynamics in Individuals With Knee Osteoarthritis · recruiting
- NCT06749340 — Examining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver Cirrhosis · NA · not yet recruiting
- NCT07367308 — External vs Combined Focus Effects on Landing in Female Athletes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06769516 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bahçeşehir University
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06769516.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing